Budapest, Hungary

Alice Druga


Average Co-Inventor Count = 17.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Alice Druga

Introduction

Alice Druga is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiarrhythmic compounds. With a total of 3 patents to her name, her work has the potential to impact the treatment of various medical conditions.

Latest Patents

Alice Druga's latest patents focus on novel, antiarrhythmically active phenoxyalkylamine derivatives. These compounds possess a double point of attack, which enhances their effectiveness. One of her notable inventions includes R-2-[3-([1,4]benzodioxan-2-ylmethylamino)-1-propyl]-3(2H)-pyridazinone, along with its S-2 counterpart. These compounds exhibit α- and β-adrenoceptor antagonistic effects and urogenital selectivity, making them useful for treating benign prostate hyperplasia. Additionally, her patents detail a process for the preparation of these compounds, showcasing her innovative approach to pharmaceutical development.

Career Highlights

Throughout her career, Alice has worked with various organizations, including Gyogyszerkutato Intezet Kft. Her experience in the pharmaceutical industry has allowed her to develop groundbreaking inventions that address critical health issues.

Collaborations

Alice has collaborated with notable professionals in her field, including Péter Mátyus and Antal Simay. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Alice Druga's innovative work in the field of pharmaceuticals highlights her dedication to improving medical treatments. Her patents reflect her expertise and commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…